Strategic biomanufacturing partner for multispecific antibodies

Multispecific antibodies, including bispecifics, represent a promising class of next-generation biologics as they offer enhanced efficacy and safety. However, their development and manufacturing present significant technical and regulatory complexities.

Our latest whitepaper outlines key considerations for addressing these challenges - from molecular design and process development to scalable manufacturing strategies.

Learn how Samsung Biologics applies seven strategic pillars to support the efficient development of multispecific antibodies.

Multispecific antibodies, including bispecifics, represent a promising class of next-generation biologics as they offer enhanced efficacy and safety. However, their development and manufacturing present significant technical and regulatory complexities.

Our latest whitepaper outlines key considerations for addressing these challenges - from molecular design and process development to scalable manufacturing strategies.

Learn how Samsung Biologics applies seven strategic pillars to support the efficient development of multispecific antibodies.